These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 5027234)

  • 21. Insulin sensitizing drugs increase the endogenous dopaminergic tone in obese insulin-resistant women with polycystic ovary syndrome.
    Ortega-González C; Cardoza L; Coutiño B; Hidalgo R; Arteaga-Troncoso G; Parra A
    J Endocrinol; 2005 Jan; 184(1):233-9. PubMed ID: 15642799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Responses of serum androgen and insulin resistance to metformin and pioglitazone in obese, insulin-resistant women with polycystic ovary syndrome.
    Ortega-González C; Luna S; Hernández L; Crespo G; Aguayo P; Arteaga-Troncoso G; Parra A
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1360-5. PubMed ID: 15598674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia/insulin resistance.
    Arslanian SA; Lewy V; Danadian K; Saad R
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1555-9. PubMed ID: 11932281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ovarian steroidogenic response to human chorionic gonadotrophin in obese women with polycystic ovary syndrome: effect of metformin.
    Koivunen RM; Morin-Papunen LC; Ruokonen A; Tapanainen JS; Martikainen HK
    Hum Reprod; 2001 Dec; 16(12):2546-51. PubMed ID: 11726572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of fasting on glucose and insulin metabolism of obese patients.
    Jackson IM; McKiddie MT; Buchanan KD
    Lancet; 1969 Feb; 1(7589):285-7. PubMed ID: 4178981
    [No Abstract]   [Full Text] [Related]  

  • 26. Therapeutic approach in insulin resistance with acanthosis nigricans.
    Tankova T; Koev D; Dakovska L; Kirilov G
    Int J Clin Pract; 2002 Oct; 56(8):578-81. PubMed ID: 12425366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pioglitazone and metformin in obese women with polycystic ovary syndrome not optimally responsive to metformin.
    Glueck CJ; Moreira A; Goldenberg N; Sieve L; Wang P
    Hum Reprod; 2003 Aug; 18(8):1618-25. PubMed ID: 12871871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Efficiency and secretion of insulin in obese children. Study using a mathemetical model].
    Cacciari E; Sarti E; Cicognani A; Pirazzoli P; Tassoni P; Zappulla F; Bernardi F; Tanas R
    Minerva Pediatr; 1978 Jul; 30(14):1125-30. PubMed ID: 672854
    [No Abstract]   [Full Text] [Related]  

  • 29. Metformin in the treatment of obesity in subjects with normal glucose tolerance.
    Tankova T; Dakovska L; Kirilov G; Koev D
    Rom J Intern Med; 2003; 41(3):269-75. PubMed ID: 15526510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Glucose utilization and plasma lipids in obese patients under the effect of dimethylbiguanide (glucophage)].
    Irsigler K
    Wien Med Wochenschr; 1969 Mar; 119(10):191-4. PubMed ID: 5769286
    [No Abstract]   [Full Text] [Related]  

  • 31. Metformin and weight loss in obese women with polycystic ovary syndrome: comparison of doses.
    Harborne LR; Sattar N; Norman JE; Fleming R
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4593-8. PubMed ID: 15886247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes.
    Lund SS; Tarnow L; Frandsen M; Smidt UM; Pedersen O; Parving HH; Vaag AA
    Eur J Endocrinol; 2008 Jan; 158(1):35-46. PubMed ID: 18166815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metformin improves peripheral but not hepatic insulin action in obese patients with type II diabetes.
    Hother-Nielsen O; Schmitz O; Andersen PH; Beck-Nielsen H; Pedersen O
    Acta Endocrinol (Copenh); 1989 Mar; 120(3):257-65. PubMed ID: 2648723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tissue expression of DPP-IV in obesity-diabetes and modulatory effects on peptide regulation of insulin secretion.
    McKillop AM; Stevenson CL; Moran BM; Abdel-Wahab YHA; Flatt PR
    Peptides; 2018 Feb; 100():165-172. PubMed ID: 29412816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term treatment with metformin in obese, insulin-resistant adolescents: results of a randomized double-blinded placebo-controlled trial.
    van der Aa MP; Elst MA; van de Garde EM; van Mil EG; Knibbe CA; van der Vorst MM
    Nutr Diabetes; 2016 Aug; 6(8):e228. PubMed ID: 27571249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protective effect of metformin in CD1 mice placed on a high carbohydrate-high fat diet.
    Hou M; Venier N; Sugar L; Musquera M; Pollak M; Kiss A; Fleshner N; Klotz L; Venkateswaran V
    Biochem Biophys Res Commun; 2010 Jul; 397(3):537-42. PubMed ID: 20573602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improvement of metabolic parameters and vascular function by metformin in obese non-diabetic rats.
    Lobato NS; Filgueira FP; Hagihara GN; Akamine EH; Pariz JR; Tostes RC; Carvalho MH; Fortes ZB
    Life Sci; 2012 Jan; 90(5-6):228-35. PubMed ID: 22154980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral chromium picolinate improves carbohydrate and lipid metabolism and enhances skeletal muscle Glut-4 translocation in obese, hyperinsulinemic (JCR-LA corpulent) rats.
    Cefalu WT; Wang ZQ; Zhang XH; Baldor LC; Russell JC
    J Nutr; 2002 Jun; 132(6):1107-14. PubMed ID: 12042418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retrospective Evaluation of Metformin and/or Metformin Plus a New Polysaccharide Complex in Treating Severe Hyperinsulinism and Insulin Resistance in Obese Children and Adolescents with Metabolic Syndrome.
    Stagi S; Ricci F; Bianconi M; Sammarco MA; Municchi G; Toni S; Lenzi L; Verrotti A; de Martino M
    Nutrients; 2017 May; 9(5):. PubMed ID: 28531113
    [No Abstract]   [Full Text] [Related]  

  • 40. [Evaluation of a new association between insulin-sensitizers and α-lipoic acid in obese women affected by PCOS].
    Cappelli V; Di Sabatino A; Musacchio MC; De Leo V
    Minerva Ginecol; 2013 Aug; 65(4):425-33. PubMed ID: 24051942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.